We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

148 hedge funds and large institutions have $839M invested in Cardiovascular Systems, Inc. in 2018 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 59 increasing their positions, 49 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more repeat investments, than reductions

Existing positions increased: 59 | Existing positions reduced: 49

3% more call options, than puts

Call options by funds: $486K | Put options by funds: $473K

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 159148 (-11)

26% less capital invested

Capital invested by funds: $1.13B → $839M (-$288M)

36% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 28

Holders
148
Holders Change
-11
Holders Change %
-6.92%
% of All Funds
3.3%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
18
Increased
59
Reduced
49
Closed
28
Calls
$486K
Puts
$473K
Net Calls
+$13K
Net Calls Change
+$1.15M
Name Holding Trade Value Shares
Change
Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$5.53M -$2.88M -90,564 -32%
Charles Schwab
27
Charles Schwab
California
$5.45M +$293K +9,215 +5%
Man Group
28
Man Group
United Kingdom
$5.22M -$831K -26,149 -12%
TAM
29
THB Asset Management
Connecticut
$5.11M -$264K -8,307 -4%
Jacobs Levy Equity Management
30
Jacobs Levy Equity Management
New Jersey
$4.63M +$577K +18,160 +13%
CM
31
Castleark Management
Illinois
$4.63M -$306K -9,620 -6%
Deutsche Bank
32
Deutsche Bank
Germany
$4.56M -$17.2M -542,588 -77%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$4.33M +$124K +3,888 +3%
Thrivent Financial for Lutherans
34
Thrivent Financial for Lutherans
Minnesota
$3.98M +$16.6K +523 +0.4%
Two Sigma Advisers
35
Two Sigma Advisers
New York
$3.88M -$217K -6,827 -5%
Two Sigma Investments
36
Two Sigma Investments
New York
$3.78M -$3.83M -120,585 -48%
Ameriprise
37
Ameriprise
Minnesota
$3.49M +$1.53M +48,313 +65%
Russell Investments Group
38
Russell Investments Group
United Kingdom
$3.25M -$260K -8,195 -7%
HSA
39
Hussman Strategic Advisors
Maryland
$3.19M +$3.56M +112,000 New
TA
40
Teton Advisors
New York
$3.17M
USAA
41
United Services Automobile Association
Texas
$3M -$121K -3,800 -3%
SAM
42
Sectoral Asset Management
Quebec, Canada
$2.87M +$3.2M +100,862 New
Morgan Stanley
43
Morgan Stanley
New York
$2.57M -$4.15M -130,785 -59%
Dimensional Fund Advisors
44
Dimensional Fund Advisors
Texas
$2.52M +$2.81M +88,326 New
QI
45
QS Investors
New York
$2.5M
GI
46
GAMCO Investors
Connecticut
$2.4M +$953 +30 +0%
PCM
47
Perkins Capital Management
Minnesota
$2.4M +$473K +14,900 +22%
MPI
48
Mairs & Power Inc
Minnesota
$2.37M +$227K +7,150 +9%
SIM
49
Spark Investment Management
New York
$2.25M +$594K +18,700 +31%
State Board of Administration of Florida Retirement System
50
State Board of Administration of Florida Retirement System
Florida
$2.24M +$1.36M +42,702 +119%

CSII Hedge Fund Activity: Q4 2018 in Review

148 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q4 2018, worth a combined $839M — down 26% from $1.13B a quarter earlier.

Sellers outnumbered buyers: 28 funds closed out of CSII and 18 opened new positions — a net loss of 10 holders — while 49 trimmed existing stakes and 59 added.

The largest buyer was PFM Health Sciences, adding an estimated $18.5M. The largest seller was Deutsche Bank, cutting an estimated $17.2M.

  • 148 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q4 2018, down from 159 in Q3 2018.
  • Funds reported $839M of Cardiovascular Systems, Inc. stock for Q4 2018, down 26% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q4 2018 and 28 closed out, a net change of -10 holders.
  • The largest Cardiovascular Systems, Inc. buyer in Q4 2018 was PFM Health Sciences, an estimated $18.5M added.
  • The largest Cardiovascular Systems, Inc. seller in Q4 2018 was Deutsche Bank, an estimated $17.2M sold.

Based on aggregated 13F filings for Q4 2018.